Perinatal exposure to antiretroviral agents: risks and benefits.
作者信息
Scott Gwendolyn B
出版信息
AJNR Am J Neuroradiol. 2005 Apr;26(4):689-92.
Abstract
摘要
相似文献
1
Perinatal exposure to antiretroviral agents: risks and benefits.
AJNR Am J Neuroradiol. 2005 Apr;26(4):689-92.
2
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.
Lancet. 1999 Sep 25;354(9184):1084-9. doi: 10.1016/S0140-6736(99)07219-0.
3
Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
Drug Saf. 2007;30(3):203-13. doi: 10.2165/00002018-200730030-00004.
4
Reducing mother-to-child transmission of HIV.
S Afr Med J. 2000 Apr;90(4):322, 324.
5
Management of HIV infection during pregnancy.
Curr Opin Obstet Gynecol. 2000 Oct;12(5):357-67. doi: 10.1097/00001703-200010000-00004.
6
The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment: what do we really know?
J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):308-11. doi: 10.1097/00126334-200311010-00009.
7
Perinatal guidelines for use of antiretroviral drugs updated.
AIDS Read. 2000 Apr;10(4):205.
8
Antiretroviral use during pregnancy and risk of preterm delivery: more questions than answers.
J Infect Dis. 2011 Aug 15;204(4):493-4. doi: 10.1093/infdis/jir318.
9
Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission.
AIDS. 2001 May 25;15(8):1074-5. doi: 10.1097/00002030-200105250-00023.
10
[HIV, breast feeding and antiretroviral agents].
Tidsskr Nor Laegeforen. 2010 Mar 11;130(5):520-2. doi: 10.4045/tidsskr.09.0933.
本文引用的文献
1
Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine.
AIDS Res Hum Retroviruses. 2004 Jan;20(1):91-100. doi: 10.1089/088922204322749530.
2
Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Pediatr Infect Dis J. 2003 Sep;22(9):782-9. doi: 10.1097/01.inf.0000086400.93257.74.
3
Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.
AIDS. 2003 Aug 15;17(12):1769-85. doi: 10.1097/00002030-200308150-00006.
4
Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.
J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):175-83. doi: 10.1097/00126334-200306010-00010.
5
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.
6
Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
N Engl J Med. 2002 Jun 13;346(24):1863-70. doi: 10.1056/NEJMoa991159.
7
Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.
Lancet. 2002 Apr 6;359(9313):1178-86. doi: 10.1016/S0140-6736(02)08214-4.
8
ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999).
Int J Gynaecol Obstet. 2001 Jun;73(3):279-81. doi: 10.1016/s0020-7292(01)00412-x.
9
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.
J Infect Dis. 2001 Feb 15;183(4):539-45. doi: 10.1086/318530. Epub 2001 Jan 12.
10
Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts.
J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):261-8. doi: 10.1097/00126334-200011010-00009.
Zotero 插件